<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03504514</url>
  </required_header>
  <id_info>
    <org_study_id>2017-A00109-44</org_study_id>
    <nct_id>NCT03504514</nct_id>
  </id_info>
  <brief_title>Evaluation of the Effect of a Speech Detection Tool on the Improvement of Phonation in Neuromuscular Patients Dependent on Mechanical Ventilation</brief_title>
  <acronym>Ventiphono</acronym>
  <official_title>Evaluation of the Effect of a Speech Detection Tool on the Improvement of Phonation in Neuromuscular Patients Dependent on Mechanical Ventilation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre d'Investigation Clinique et Technologique 805</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre d'Investigation Clinique et Technologique 805</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ventilation is a major treatment of respiratory failure due to neuromuscular disorders. First&#xD;
      line treatment is noninvasive ventilation (NIV) but in some situations, especially in case of&#xD;
      NIV inefficiency, invasive ventilation with tracheostomy (IVT) may be required. In both&#xD;
      situations, patients may become dependent on ventilatory support with the disease evolution.&#xD;
      Ventilation then can interfere speech and the quality of communication of the patients.&#xD;
      Modification of the ventilation parameters may result in improved speech quality (for&#xD;
      example, positive expiratory pressure (PEP) while not necessary for ventilation quality can&#xD;
      dramatically improve speech in tracheostomized patients). Therefore, it would be of interest&#xD;
      to allow patients to benefit from these specific parameters when they need to speak without&#xD;
      maintaining them when patients are not speaking. We want to evaluate a specific ventilator&#xD;
      feature which can detect speech and switch to specific ventilation parameters adapted for&#xD;
      speech We believe that this feature will improve significantly speech quality in patients&#xD;
      dependant either on NIV or IVT.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nowadays, the first line treatment of chronic respiratory failure in neuromuscular disorder&#xD;
      is non invasive ventilation (NIV). However, while NIV can compensate the respiratory&#xD;
      disability and significantly delays significantly the necessity for invasive ventilation with&#xD;
      a tracheostomy (IVT), it is used for significant periods of time during daytime in patients&#xD;
      with severe respiratory failure and can therefore interfere with patients' speech. Moreover,&#xD;
      if NIV becomes inefficient, IVT may be required to pursue ventilatory support to treat the&#xD;
      respiratory failure; tracheostomy also interferes with phonation and specific adaptations are&#xD;
      necessary to optimize phonation and speech quality.&#xD;
&#xD;
      Adaptation of ventilation parameters (mainly triggering sensitivity and use of positive&#xD;
      expiratory pressure (PEP)) can significantly improve speech quality and therefore ventilated&#xD;
      patients' communication. These adapted parameters are not strictly necessary for ventilation&#xD;
      outside of speaking periods. It would be of interest to be able to use them exclusively&#xD;
      during speech. In neuromuscular patients, the major motor disability constitutes a challenge&#xD;
      as most patients are unable to use themselves the controls of their ventilator (and to&#xD;
      potentially switch to a speech adapted ventilation program). We want to evaluate a device&#xD;
      able to automatically detect speech and to transitorily switch from the patient's usual&#xD;
      ventilation parameters to speech specific parameters set to optimize phonation quality.&#xD;
&#xD;
      Specific adaptations differs between NIV or IVT, therefore we will evaluation two groups of&#xD;
      ventilation dependent patients divided according to their ventilation mode.&#xD;
&#xD;
      We believe that this device may improve the speech of NIV patients as well as IVT patients.&#xD;
      Patients would benefit from an appropriate ventilator support without any ventilation&#xD;
      desynchronization during speech. Speech would be more fluent and natural which would result&#xD;
      in improved communication.&#xD;
&#xD;
      Objectives The main objective of this study is to demonstrate that phonation is improved by&#xD;
      the use of a device allowing the transitory switch to specific speech parameters of&#xD;
      ventilation in neuromuscular ventilator dependent patient whether during NIV or during IMT.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">November 6, 2019</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>monocentric, open, randomized, crossover study</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>reading duration</measure>
    <time_frame>15 minutes</time_frame>
    <description>duration for reading a specific text in seconds</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vocal flow</measure>
    <time_frame>15 minutes</time_frame>
    <description>vocal flow in syllables/second during the reading of a specific text</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vocal range</measure>
    <time_frame>2 minutes</time_frame>
    <description>vocal range from lowest to highest pitch</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intelligibility</measure>
    <time_frame>15 minutes</time_frame>
    <description>evaluation of intelligibility during reading evaluated by listeners blinded to ventilation conditions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Speech quality</measure>
    <time_frame>5 min</time_frame>
    <description>evaluation of prosodia by listeners blinded to ventilation conditions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Speech quality</measure>
    <time_frame>1 minute</time_frame>
    <description>evaluation of speech quality by the patient using a visual analogical scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Speech comfort</measure>
    <time_frame>1 minute</time_frame>
    <description>evaluation of speech comfort by the patient using a visual analogical scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory comfort</measure>
    <time_frame>1 minute</time_frame>
    <description>evaluation of respiratory comfort by the patient using a visual analogical scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dyspnea</measure>
    <time_frame>1 minute</time_frame>
    <description>evaluation of dyspnea during speech evaluated with the modified Borg scale (ranking from 0 to10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>oxygen saturation</measure>
    <time_frame>15 min</time_frame>
    <description>evaluation of Respiratory tolerance during speech by measuring oxygen saturation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>respiratory rate</measure>
    <time_frame>15 min</time_frame>
    <description>evaluation of Respiratory tolerance during speech by measuring respiratory rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cardiac frequency</measure>
    <time_frame>15 min</time_frame>
    <description>evaluation of Cardiovascular tolerance during speech by measuring cardiac frequency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>1 minute</time_frame>
    <description>evaluation of Patient satisfaction with speech with the ventilation mode by the patient using a visual analogical scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Neuromuscular Diseases</condition>
  <condition>Mechanical Ventilation</condition>
  <condition>Speech</condition>
  <arm_group>
    <arm_group_label>Conventional mechanical ventilation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Conventional mechanical ventilation, with patient ventilator usual parameters</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adapted mechanical ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mechanical ventilation with parameters specifically modified to improve speech the effect is evaluated with speech trials during different ventilation conditions</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>speech trials during different ventilation conditions</intervention_name>
    <description>ventilator parameters are modified</description>
    <arm_group_label>Adapted mechanical ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>speech trial</intervention_name>
    <description>reading duration, vocal flow, intelligibility and voice quality will be evaluated during speech</description>
    <arm_group_label>Adapted mechanical ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult patients (age &gt; or equal to 18)&#xD;
&#xD;
          -  Neuromuscular patients with a restrictive respiratory failure without major bulbar&#xD;
             involvement.&#xD;
&#xD;
          -  Adult patient.&#xD;
&#xD;
          -  Ventilator dependancy= ventilation duration of 16h/day or more either with NIV or IMT&#xD;
&#xD;
          -  Leak ventilation for IMT patients&#xD;
&#xD;
          -  Respiratory autonomy of at leat 1h per day&#xD;
&#xD;
          -  Usual ventilation mode : assist control mode (either pressure or volume controlled&#xD;
             mode) ou spontaneous breathing mode with target volume&#xD;
&#xD;
          -  Stable hemodynamic state&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal to participate&#xD;
&#xD;
          -  Use of cuffed tracheostomy tube&#xD;
&#xD;
          -  Inability to read&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Protected adults&#xD;
&#xD;
          -  Acute respiratory failure&#xD;
&#xD;
          -  Hemodynamic instability&#xD;
&#xD;
          -  not registered with the social security system&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hélène Prigent, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Raymond Poincaré Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hélène Prigent, MD PhD</last_name>
    <phone>0033147107911</phone>
    <email>helene.prigent@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Isabelle BOSSARD</last_name>
    <phone>0033147104615</phone>
    <email>isabelle.bossard@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Raymond Poincaré hospital</name>
      <address>
        <city>Garches</city>
        <zip>92380</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hélène PRIGENT, MD PhD</last_name>
      <phone>0033147107911</phone>
      <email>helene.prigent@aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Isabelle BOSSARD</last_name>
      <phone>0033147104615</phone>
      <email>isabelle.bossard@aphp.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Hélène PRIGENT, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>April 12, 2018</study_first_submitted>
  <study_first_submitted_qc>April 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2018</study_first_posted>
  <last_update_submitted>November 15, 2019</last_update_submitted>
  <last_update_submitted_qc>November 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>non invasive ventilation</keyword>
  <keyword>invasive ventilation</keyword>
  <keyword>neuromuscular disorder</keyword>
  <keyword>phonation</keyword>
  <keyword>speech</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuromuscular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

